Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -10.01 is 83% above its 5-year average of -58.09, near the high end of its 5-year range (-227.58–-4.94).
8.38% above its 12-month average of -10.93.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-10.01
EARNINGS PER SHARE (EPS) AVG TTM
-10.93
EARNINGS PER SHARE (EPS) AVG 3Y
-75.63
EARNINGS PER SHARE (EPS) AVG 5Y
-58.09
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+8.38%
CURRENT VS 3Y AVG
+86.76%
CURRENT VS 5Y AVG
+82.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Korro Bio, Inc.
Market Cap
$97.84M
Earnings Per Share (EPS)
-10.01
TTM Avg
-10.93
3Y Avg
-75.63
5Y Avg
-58.09
Market Cap
$96.80M
Earnings Per Share (EPS)
-0.69
TTM Avg
-0.71
3Y Avg
-1.04
5Y Avg
-1.15
Market Cap
$99.27M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$98.56M
Earnings Per Share (EPS)
-1.48
TTM Avg
-3.50
3Y Avg
-21.30
5Y Avg
-30.60
Market Cap
$94.27M
Earnings Per Share (EPS)
-0.91
TTM Avg
0.49
3Y Avg
1.23
5Y Avg
1.23
Market Cap
$92.92M
Earnings Per Share (EPS)
-0.50
TTM Avg
-2.50
3Y Avg
-2.81
5Y Avg
-2.25
Market Cap
$103.09M
Earnings Per Share (EPS)
-0.30
TTM Avg
-0.36
3Y Avg
-0.38
5Y Avg
-0.40
Market Cap
$103.07M
Earnings Per Share (EPS)
0.27
TTM Avg
-0.10
3Y Avg
-0.20
5Y Avg
0.10
Market Cap
$102.56M
Earnings Per Share (EPS)
-3.50
TTM Avg
-4.18
3Y Avg
-3.30
5Y Avg
-7.15
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korro Bio, Inc. (KRRO) | $97.84M | -10.01 | -10.93 | -75.63 | -58.09 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.80M | -0.69 | -0.71 | -1.04 | -1.15 |
| Conexeu Sciences Inc. (CNXU)vs › | $99.27M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $98.56M | -1.48 | -3.50 | -21.30 | -30.60 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $94.27M | -0.91 | 0.49 | 1.23 | 1.23 |
| Biomea Fusion, Inc. (BMEA)vs › | $92.92M | -0.50 | -2.50 | -2.81 | -2.25 |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | -0.30 | -0.36 | -0.38 | -0.40 |
| The Joint Corp. (JYNT)vs › | $103.07M | 0.27 | -0.10 | -0.20 | 0.10 |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.56M | -3.50 | -4.18 | -3.30 | -7.15 |
| electroCore, Inc. (ECOR)vs › | $90.38M | -1.70 | -1.62 | -2.84 | -4.12 |
Trailing EPS (TTM)
$-10.01
Forward EPS (Est.)
$-5.31
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -12.48 |
| 2024-12-31 | -9.37 |
| 2023-12-31 | -53.09 |
| 2022-12-31 | -227.58 |
| 2021-12-31 | -4.94 |
| 2020-12-31 | -41.10 |
| 2019-12-31 | -30.39 |
| 2018-12-31 | -30.57 |
| 2017-12-31 | -32.27 |
